Maxim Group Starts Prima Biomed (PBMD) at Buy, $4 PT

April 18, 2016 4:59 PM EDT Send to a Friend
Maxim Group initiates coverage on Prima Biomed (NASDAQ: PBMD) with a Buy rating and a price target of $4.00.Analyst Jason ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login